Bristol-Myers Squibb Co. - Bio, News, Photos

Amgen to spend $13.4B on Celgene psoriasis drug Otezla

By The Associated Press - Associated Press

Bristol-Myers: 2Q Earnings Snapshot

Associated Press

Bristol-Myers: 1Q Earnings Snapshot

Associated Press

W.Va. settles complaint with drug makers over blood thinner

Associated Press

Bristol-Myers Squibb buying Celgene in $74B deal

Associated Press

High court sides with drugmaker in Plavix lawsuit

Associated Press

Official: Bristol-Myers Squibb to pay to settle allegations

Associated Press

Cancer drug sales boost Bristol-Myers Squibb performance

Associated Press

Bristol-Myers completes diabetes business sale

By NEW YORK - Associated Press

Sales up, 4th-quarter net falls for Bristol-Myers

By LINDA A. JOHNSON - Associated Press

New coupons aim to keep people off generic drugs

By LINDA A. JOHNSON - Associated Press

FDA delays decision on Pfizer, Bristol-Myers drug

By LINDA A. JOHNSON - Associated Press

Bristol ups hepatitis C game in $2.5B acquisition

By ASSOCIATED PRESS - Associated Press

FDA adds new warnings to Bristol cancer drug

By ASSOCIATED PRESS - Associated Press

Bristol-Myers pitches its cancer medicine pipeline

By LINDA A. JOHNSON - Associated Press

Watch

Court Watch 'Climate Lawfare' forum: Supreme Court to weigh Suncor v. Boulder dispute

LISTEN: The bureaucracy of war and disease Michael Pack joins Bold and Blunt

LISTEN: Here’s how F-35 ejection seats are made Matt Johnson joins Threat Status

WATCH: Western tolerance and ‘suicidal empathy’ Jed Babbin joins Kelly Sadler

Topic - Bristol-Myers Squibb Co.

Related Stories

Amgen to spend $13.4B on Celgene psoriasis drug Otezla

Bristol-Myers: 2Q Earnings Snapshot

Bristol-Myers: 1Q Earnings Snapshot

W.Va. settles complaint with drug makers over blood thinner

Bristol-Myers Squibb buying Celgene in $74B deal

High court sides with drugmaker in Plavix lawsuit

Official: Bristol-Myers Squibb to pay to settle allegations

Cancer drug sales boost Bristol-Myers Squibb performance

Bristol-Myers completes diabetes business sale

Sales up, 4th-quarter net falls for Bristol-Myers

New coupons aim to keep people off generic drugs

FDA delays decision on Pfizer, Bristol-Myers drug

Bristol ups hepatitis C game in $2.5B acquisition

FDA adds new warnings to Bristol cancer drug

Bristol-Myers pitches its cancer medicine pipeline